MedTrace Logo

The Antiaggregation Monitoring (TAM) Registry

NCT01329224 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-10-22

No results posted yet for this study

Summary

The purpose of this study is to investigate the incidence of acetylsalicylic acid resistance (ASA-R) among patients under chronic acetylsalicylic acid(ASA) treatment seen at our outpatient clinic.

Conditions

  • Aspirin Causing Adverse Effects in Therapeutic Use

Interventions

OTHER

Measurement of platelet anti-aggregation

Whole blood impedance platelet aggregometry was performed with the Multiplate analyzer (Dynabyte, Munich, Germany) to test the response to ASA with arachidonic acid as the trigger.

Sponsors & Collaborators

  • Stephane Cook

    lead OTHER

Principal Investigators

  • Stéphane Cook, Prof · Fribourg University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-04-30
Completion
2011-04-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01329224 on ClinicalTrials.gov